Merck & Co is to close or sell eight manufacturing plants and a further eight R&D laboratories as part of efforts to cuts its workforce by 15 per cent.
InhibOx and the Cambridge Crystallographic Data Centre (CCDC) say new drug discovery services partnership is motivated by market need for CADD expertise.
Contract services firm Albany Molecular Research (AMRI) hopes discovery deal with Aquapharm Biodiscovery will make a big splash in anti-microbials and anti-inflammatories.
Millipore is targeting protein manufacturers with a new chromatography resin that, the firm claims, offers flexibility and high throughput with a small manufacturing footprint.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments West Pharmaceutical Services, Unilife and ACR Image Metrix.
Sagent Pharmaceuticals’ heparin sodium injection, USP, which uses packaging and labelling safety features, has been approved by the US Food and Drug Administration (FDA).
Pharming has entered into a toll manufacturing agreement with Sanofi Chemie to boost capacity, secure supply and lower costs of Ruconest (conestat alfa).
Contract research organisation (CRO) Diteba Research Labs says partnership with fellow Canadian-based Thesis Chemistry reflects increasing customer demand for API and intermediate synthesis.
The rapidly evolving Asian drug manufacturing sector represents both an opportunity and a challenge for the fine chemicals and molecules industry, according to SAFC president Gilles Cottier.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Elan, Inspire Pharmaceuticals, BioVex and Lux Biosciences.
Chemicals manufacturer BASF reorganises Swiss business to cut active pharmaceutical ingredient (API) manufacturing site complexity and simplify process operations.
Ireland-based Firecrest Clinical says focusing on trial specific training and visits for principal investigators can speed recruitment, cut protocol deviations and produce cleaner data.
Quintiles is establishing its first Prime Site in Asia by entering into a strategic alliance with the University Malaya Medical Centre (UMMC) in Malaysia.
Rumour has it that French drug giant Sanofi Aventis is planning to make a $20bn (€16bn) acquisition in the US with speculation that biotechs like Allergan, Biogen Idec and Genzyme are among the targets.
The opening of a New York office will help communicate Clintec’s global reach to US Pharmaceutical according to new associate director of US business operations, Susan Pavone.
GlaxoSmithKline (GSK) and the Singapore EDB are to fund eight research projects into green and sustainable production of pharmaceuticals and fine chemicals.
Abbott Laboratories has confirmed it is considering the sale of the vaccines unit it gained with the €4.5bn ($6.2bn) acquisition of Solvay Pharmaceuticals in February.
Indian CROs Max Neeman International and QED Pharmaceutical Services have both added US Food and Drug Administration’s (FDA) CDISC compliance to their data management offering this month.
Demand for biomarker analysis is strong, but the pace of technological change is causing an investment headache for CROs according to a new report by Industry Standard Research (ISR).
India’s oldest pharmaceutical company Alembic went one step closer to the biggest restructuring in its history as its board approved the demerging of its main pharmaceutical business into a separate subsidiary company, Alembic Pharma.
Sanofi-Aventis will build a new manufacturing plant in King Abdullah Economic City (KAEC) in Saudi Arabia through an agreement with the Emaar development company (ECC).
The Singaporean government has launched two new certification courses for clinical researchers in a bid to “deepen the pool of skilled manpower” available to the country’s rapidly expanding contract research sector.
West Pharmaceutical Services and Japan’s Daikyo Seiko team on container technology they claim will help drugmakers ensure consistency during scale-up operations
Results from PAT humidity monitoring research will improve API granulation process, product yields and reduce variability during drug manufacture, says NextPharma.
Piramal Healthcare has signalled its intent to enter the biotechnology sector with its acquisition of BioSyntech in a deal worth $3.8m and includes full access to BioSyntech’s proprietary biotherapeutic thermogel technology.
A US group representing hospitals in New York wants to accelerate clinical research process by improving trial access to electronic patient records, while maintaining patient privacy.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing space, including appointments at DPT, PPD, ACR Image Metrix, NexMed, ResearchPoint, CEDRA, Chemspec and Covance.
New Gerresheimer CEO Uwe Roehrhoff wants the German firm to become the pharmaceutical and biopharmaceutical industry “first choice” partner for high-tech packaging.
US CRO Kendle has opened a new services centre in India, attracted by the country’s thriving contract research sector and favourable climate for clinical trials.
A new technique developed by researchers has yielded results, which suggests that drug production and manufacturing can essentially be achieved without toxic by-products.
US drugmaker Merck & Co’s new deal with Adcock Ingram proves the FIFA football World Cup isn’t the only thing attracting people to South Africa this summer.
ViroPharma is seeking permission from the Food and Drug Administration (FDA) to increase production of Cinryze to an industrial scale as part of its ongoing expansion activities.